Cansino Biologics Ownership

Cansino Biologics holds a total of 114.78 Million outstanding shares. Cansino Biologics shows majority of its outstanding shares owned by insiders. An insider is usually defined as a corporate executive, director, member of the board or institutional investor who own at least 10% of the company's outstanding shares. 62.9 percent of Cansino Biologics outstanding shares that are owned by insiders signifies that they have been buying or selling the stock in recent months in anticipation of some upcoming event. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it. Some institutional investors establish a significant position in stocks such as Cansino Biologics in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of Cansino Biologics, and when they decide to sell, the stock will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits. As of November 25, 2024, Dividends Paid is expected to decline to about 60.8 M. As of November 25, 2024, Common Stock Shares Outstanding is expected to decline to about 259.1 M. The current year's Net Loss is expected to grow to about (993.6 M). Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cansino Biologics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.